<DOC>
	<DOCNO>NCT02015598</DOCNO>
	<brief_summary>Obstructive sleep apnoea syndrome ( OSAS ) characterise repeat episode upper airway occlusion sleep.It cause cycle hypoxia reoxygenation . And postulate intermittent hypoxia seem resemble ischemia-reperfusion.Many study suggest ischemia-reperfusion represent oxidative stress cause increase generation reactive oxygen specie , especially superoxide anions.It one important mechanism cardiovascular disease , include hypertension , coronary artery disease cerebrovascular accident complication OSAS.So many individual approve OSAS Oxidative Stress disease . Continuous positive airway pressure ( CPAP ) first-line treatment method moderate/severe OSA.But poor adherence CPAP treatment common.The failure rate CPAP treatment 50 % .So search new treatment patient . Carbocysteine antioxidant.It scavenges free radical also replenish glutathione ( GSH ) double antioxidant capacity . However , Carbocysteine cheaper double antioxidant capacity drug , N-acetylcysteine.The purpose evaluate efficacy oral intake Antioxidant Carbocysteine witch reduce oxidative stress improve symptom OSAS.It recover imbalance oxidant-anti-oxidant status may reduce cardiovascular abnormality Patients OSAS .</brief_summary>
	<brief_title>Antioxidant Carbocysteine Treatment Obstructive Sleep Apnoea Syndrome</brief_title>
	<detailed_description>OSAS patient require fill questionnaire.And Inflammation biomarkers Oxidative Stress biomarkers ultrasonic tested.Then patient randomly allocate one two group . One group treat oral intake Antioxidant Carbocysteine 500mg tid . The second group treat CPAP . After 6 week treatment , patient take overnight polysomnogram test , take questionnaire , blood , ultrasonic test .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Carbocysteine</mesh_term>
	<criteria>1 . Male age range 18 65 year 2 . Obstructive Sleep Apnoea Apnea Hypopnea Index ( AHI ) great equal 15 confirm polysomnography 3 . The patient able provide consent 4 . The patient receive therapy sleep apnoea , CPAP surgery . 1 . Inability tolerate Carbocysteine CPAP 2 . Treatment CPAP surgery prior time enrolment 3. presence active acute chronic infection 4 . Patients unstable cardiovascular disease ( unstable angina , myocardial infarction , stroke , transient ischemic attack ) , neuromuscular disease , chronic respiratory disease , peripheral vascular disease 5 . Using steroidal , nonsteroidal antiinflammatory , vasodilator , lipidlowering drug , medication lower oxidative stress . 6 . Intake central relevant drug , sedative , drug impair sleep 7 . Unwilling participate study 8 . Participation another clinical study past 4 week 9 . Shift worker</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Obstructive sleep apnoea</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>drug treatment</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>Continuous Positive Airway Pressure</keyword>
</DOC>